Previous 10 | Next 10 |
Timely, edifying episode with industry expert Brady Cobb. Recent cannabis legislation; moving from optics to real reform. SAFE Banking, uplisting and what it all means for cannabis investors. MSOs, ETFs new and old, future valuations, Florida and NY/NJ markets. Selling to Cres...
Q3 results in line with estimates. 22 Target Revenue remains $800M, adjusted EBITDA guidance reduced on low end, now at $250M to $300M (was $300M). Expanding presence in IL with Dispensary 33 acquisition. Confident that additional M&A looms given management interest and ca...
Q3/21 miss on pricing pressure. Expect lower flower pricing to continue into 2022. Pricing pressure furthers our positive view on LOWLF’s differentiated initiatives put in place by management including brand acquisition, buildout of processing business and decision not to a...
Q3/21 EBITDA miss on delayed product approval in PA, MA cultivation underperformance and inflated freight costs. Expect freight costs to linger into ’22. Management reduced ’21 adjusted EBITDA guidance by nearly 20% at midpoint while stating that revenues would come ...
Q3/21 results were just the second as a vertically integrated operator. Continue to forecast strong growth and margin expansion as operations scale and acquired assets are integrated. Believe could be a takeout candidate as MSOs continue to target Colorado and other mature US cann...
An executive panel discussion that makes sense of cannabis investing today, including the recent Republican led bill, JPMorgan trading restrictions and SAFE banking. All star panel includes Blake Schroeder, CEO of Medical Marijuana, Luis Merchan, CEO of Flora Growth and Becky Postar, ...
Marimed (MRMD) is a cultivator, producer, and distributor of medicinal and recreational cannabis. It sells its products through a variety of different brands and means and also licenses its brands and product formulations. Currently, the company has 7 dispensaries and is in the process of ope...
Greenlane Holdings and KushCo recently merged to become one of the biggest makers of cannabis accessories. CEO Nick Kovacevich on margins and why the merger made sense. Getting to profitability and the broader sell-off in cannabis. For further details see: Greenlane CEO ...
Alternative Harvest ETF is one of the best funds for exposure to the cannabis sector. It is among the largest, oldest and most liquid. MJ price has been well off its peak, while most other major asset classes have had their valuations stretched thin in the past several months. Rat...
I talked to Oren Shuster, CEO of IM Cannabis, this week in Tel Aviv at its CannaBIZ conference. We discuss the significant share price decline in the industry across the board; the significance of the Republican announcement. Israel's unique market, comparisons to Michigan; German...
News, Short Squeeze, Breakout and More Instantly...
ETFMG Alternative Harvest Company Name:
MJ Stock Symbol:
NYSE Market:
CHICAGO, June 27, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces June income distributions for its ETFs. About Amplify ETFs Amplify ETFs, sponsored by Amplify Investments, has over $9 billion in assets across its suite of ETFs (as of 5/31/2024). Amplify ETFs deliver expanded in...
CHICAGO, March 26, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces March income distributions for its ETFs. About Amplify ETFs Amplify ETFs, sponsored by Amplify Investments, has over $9.1 billion in assets across its suite of ETFs (as of 1/26/2024). Amplify ETFs deliver expanded ...